Showing results (481-490 of 709) with videos related to

Sort By:
Pageof 71
Diagnostics (Basel, Switzerland)|May 28, 2022
Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver CirrhosisLeonard Kaps, Lejla Lukac, Maurice Michel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
Drug Design, Development and Therapy|November 26, 2015
Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan and Mowel after liver transplantationJohanna Vollmar, Maren Christina Bellmann, Felix Darstein, et al.
Journal of Hepatology|July 13, 2016
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factorsNadine Gehrke, Marcus A Wörns, Yvonne Huber, et al.
European Journal of Internal Medicine|May 17, 2011
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndromeAnca Zimmermann, Tim Zimmermann, Jörn Schattenberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 17, 2020
Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network: A Pilot StudyAline Mähringer-Kunz, Franziska Wagner, Felix Hahn, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2014
Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantationHarald Farnik, Tim Zimmermann, Eva Herrmann, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Liver Cancer|September 28, 2023
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III StudyMasatoshi Kudo, Richard S Finn, Peter R Galle, et al.
Pageof 71